IMMUNE Pharmaceuticals Oncology Subsidiary CYTOVIA Announces the Filing of a WorldWide Patent Protecting the Use of Ceplene in Acute Myeloid Leukemia AML and Other Hematological Cancers with MutatedÂNPM1

Favorable relapsefree and overall survival in AML patients with persistent leukemic cells Cytovia Inc. Cytovia the oncology subsidiary of Immune Pharmaceuticals Inc. NASDAQIMNP "Immune" or the Company a clinical s...